Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Polish Journal of Pharmacology and Pharmacy|October 1, 1981
Effects of antihistaminic drugs in tests for antidepressant actionZ Rogóz, G Skuza, H Sowińska
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activityJ Maj, G Skuza, Z Rogóz
Polish Journal of Pharmacology|January 1, 1997
Neuropsychopharmacological profile of remoxipride in comparison with clozapineG Skuza, Z Rogóz, A Wieczorek
Polish Journal of Pharmacology|May 5, 1998
EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine systemG Skuza, Z Rogóz, K Gołembiowska
Polish Journal of Pharmacology|November 3, 1998
Pharmacological profile of venlafaxine, a new antidepressant, given acutelyZ Rogóz, M Dziedzicka-Wasylewska, J Maj
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|July 2, 2003
Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in ratsZ Rogóz, D Dlaboga, M Dziedzicka-Wasylewska
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulationJ Maj, Z Rogóz, G Skuza, et al.
Polish Journal of Pharmacology and Pharmacy|July 1, 1992
The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming testJ Maj, Z Rogóz, G Skuza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Roxindole, a potential antidepressant. I. Effect on the dopamine systemJ Maj, K Kolodziejczyk, Z Rogóz, et al.
Pageof 9